GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fleury SA (GREY:FLRYF) » Definitions » Research & Development

Fleury (Fleury) Research & Development : $0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Fleury Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Fleury's Research & Development for the three months ended in Mar. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0 Mil.

Fleury Research & Development Historical Data

The historical data trend for Fleury's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fleury Research & Development Chart

Fleury Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fleury Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fleury Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fleury  (GREY:FLRYF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fleury Research & Development Related Terms

Thank you for viewing the detailed overview of Fleury's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Fleury (Fleury) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fleury SA (GREY:FLRYF) » Definitions » Research & Development
Comparable Companies
BSP:DASA3 BSP:AALR3 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT XPAR:BIM EXAS RVTY XPAR:ERF ASX:SHL
Traded in Other Exchanges
FLRY3:Brazil
Address
Avenida Morumbi 8.860, Itaim Bibi, Sao Paulo, SP, BRA, 4344903
Website
https://www.fleury.com.br
Fleury SA is engaged in the provision of medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics and ophthalmology areas and offers its digital healthcare platform. The company carries out its activities through customer service units and hospital-based units. Furthermore, the company has a mobile service operation with coverage in municipalities in addition to a digital platform.

Fleury (Fleury) Headlines

No Headlines